Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inflammasome-regulated cytokines are critical mediators of acute lung injury.
Dolinay T, Kim YS, Howrylak J, Hunninghake GM, An CH, Fredenburgh L, Massaro AF, Rogers A, Gazourian L, Nakahira K, Haspel JA, Landazury R, Eppanapally S, Christie JD, Meyer NJ, Ware LB, Christiani DC, Ryter SW, Baron RM, Choi AM. Dolinay T, et al. Among authors: eppanapally s. Am J Respir Crit Care Med. 2012 Jun 1;185(11):1225-34. doi: 10.1164/rccm.201201-0003OC. Epub 2012 Mar 29. Am J Respir Crit Care Med. 2012. PMID: 22461369 Free PMC article.
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
Agarwal R, Tu W, Farjat AE, Farag YMK, Toto R, Kaul S, Lawatscheck R, Rohwedder K, Ruilope LM, Rossing P, Pitt B, Filippatos G, Anker SD, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Agarwal R, et al. Ann Intern Med. 2023 Dec;176(12):1606-1616. doi: 10.7326/M23-1023. Epub 2023 Dec 5. Ann Intern Med. 2023. PMID: 38048573 Clinical Trial.
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.
Rossing P, Anker SD, Filippatos G, Pitt B, Ruilope LM, Birkenfeld AL, McGill JB, Rosas SE, Joseph A, Gebel M, Roberts L, Scheerer MF, Bakris GL, Agarwal R; FIDELIO-DKD and FIGARO-DKD Investigators. Rossing P, et al. Diabetes Care. 2022 Dec 1;45(12):2991-2998. doi: 10.2337/dc22-0294. Diabetes Care. 2022. PMID: 35972218 Free PMC article. Clinical Trial.
LECT-2 amyloidosis: what do we know?
Mann BK, Bhandohal JS, Cobos E, Chitturi C, Eppanapally S. Mann BK, et al. Among authors: eppanapally s. J Investig Med. 2022 Feb;70(2):348-353. doi: 10.1136/jim-2021-002149. Epub 2021 Nov 30. J Investig Med. 2022. PMID: 34848562 Review.
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P, Joseph A, Kolkhof P, Nowack C, Schloemer P, Ruilope LM; FIGARO-DKD Investigators. Pitt B, et al. N Engl J Med. 2021 Dec 9;385(24):2252-2263. doi: 10.1056/NEJMoa2110956. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449181 Clinical Trial.
Acute Interstitial Nephritis: A Rare and Unusual Side Effect of Omalizumab.
Yang R, Moosavi L, Eppanapally S, Aboeed A, Munoz A. Yang R, et al. Among authors: eppanapally s. J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620946890. doi: 10.1177/2324709620946890. J Investig Med High Impact Case Rep. 2020. PMID: 32744093 Free PMC article.
A Rare Case of Spontaneous Bilateral Subcapsular Renal Hematoma.
Bajaj T, Trang N, Nasrawi F, Eppanapally S. Bajaj T, et al. Among authors: eppanapally s. J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620918098. doi: 10.1177/2324709620918098. J Investig Med High Impact Case Rep. 2020. PMID: 32401061 Free PMC article.